The blockade of IL-6 receptor by the humanized anti-IL-6 receptor antibody tocilizumab has been used in the treatment of rheumatoid arthritis,50 and a human anti-IL-6 monoclonal antibody, sirukumab, has been under evaluation in patients, including those with rheumatoid arthritis. This evidence concerns the gene IL6 and rheumatoid arthritis.